$ALXA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Alexza Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Alexza Pharmaceuticals Inc.. Get notifications about new insider transactions in Alexza Pharmaceuticals Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | D | 8.00 | 272,728 | 2,181,824 | 0 | |
Jan 28 2011 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Sell | J | 0.00 | 15,883 | 0 | 6,587 | 22.5 K to 6.6 K (-70.69 %) |
Jan 28 2011 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Gift | G | 0.00 | 22,059 | 0 | 158,395 | 136.3 K to 158.4 K (+16.18 %) |
Jan 28 2011 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Gift | G | 0.00 | 22,059 | 0 | 0 | 22.1 K to 0 (-100.00 %) |
Jan 21 2011 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO, GC & Sec | Grant | A | 0.00 | 45,582 | 0 | 92,691 | 47.1 K to 92.7 K (+96.76 %) |
Jan 21 2011 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & Q ... | Grant | A | 0.00 | 45,582 | 0 | 76,309 | 30.7 K to 76.3 K (+148.35 %) |
Jan 21 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Grant | A | 0.00 | 45,582 | 0 | 57,801 | 12.2 K to 57.8 K (+373.04 %) |
Jan 21 2011 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Grant | A | 0.00 | 91,135 | 0 | 102,325 | 11.2 K to 102.3 K (+814.43 %) |
Dec 03 2010 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Gift | G | 0.00 | 69,070 | 0 | 185,177 | 116.1 K to 185.2 K (+59.49 %) |
Dec 03 2010 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Gift | G | 0.00 | 69,070 | 0 | 11,190 | 80.3 K to 11.2 K (-86.06 %) |
Jun 04 2010 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Sell | J | 0.00 | 13,452 | 0 | 22,470 | 35.9 K to 22.5 K (-37.45 %) |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | Barron Hal | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | FRAZIER ALAN D | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | BUSSER ANDREW L | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 3.52 | 6,250 | 22,000 | 6,250 | |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Gift | G | 0.00 | 18,683 | 0 | 136,336 | 117.7 K to 136.3 K (+15.88 %) |
May 20 2010 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Gift | G | 0.00 | 18,683 | 0 | 22,059 | 40.7 K to 22.1 K (-45.86 %) |
May 07 2010 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | M | 1.38 | 10,000 | 13,800 | 82,727 | |
May 07 2010 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 3.50 | 10,000 | 35,000 | 43,222 | 53.2 K to 43.2 K (-18.79 %) |
May 07 2010 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Buy | M | 1.38 | 10,000 | 13,800 | 53,222 | 43.2 K to 53.2 K (+23.14 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | Barron Hal | Director | Grant | A | 0.00 | 18,908 | 0 | 34,922 | 16 K to 34.9 K (+118.07 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Grant | A | 0.00 | 18,908 | 0 | 35,922 | 17 K to 35.9 K (+111.13 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | FRAZIER ALAN D | Director | Grant | A | 0.00 | 21,008 | 0 | 38,802 | 17.8 K to 38.8 K (+118.06 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Grant | A | 0.00 | 18,908 | 0 | 116,925 | 98 K to 116.9 K (+19.29 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Grant | A | 0.00 | 18,908 | 0 | 34,922 | 16 K to 34.9 K (+118.07 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | BUSSER ANDREW L | Director | Grant | A | 0.00 | 18,908 | 0 | 22,912 | 4 K to 22.9 K (+472.23 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Grant | A | 0.00 | 22,059 | 0 | 40,742 | 18.7 K to 40.7 K (+118.07 %) |
Jan 28 2010 | ALXA | Alexza Pharmaceuti ... | COLELLA SAMUEL D | Director | Grant | A | 0.00 | 19,958 | 0 | 36,862 | 16.9 K to 36.9 K (+118.07 %) |
Dec 30 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 2.37 | 49,626 | 117,614 | 49,626 | |
Dec 30 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 2.37 | 99,219 | 235,149 | 99,219 | |
Dec 30 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | A | 2.37 | 49,626 | 117,614 | 49,626 | |
Dec 30 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & Q ... | Option Exercise | A | 2.37 | 49,626 | 117,614 | 49,626 | |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 2.13 | 12,408 | 26,391 | 12,214 | 24.6 K to 12.2 K (-50.39 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 2.20 | 4,284 | 9,428 | 24,622 | 28.9 K to 24.6 K (-14.82 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 2.41 | 7,732 | 18,612 | 28,906 | 36.6 K to 28.9 K (-21.10 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 2.13 | 22,858 | 48,617 | 75,851 | 98.7 K to 75.9 K (-23.16 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 2.20 | 7,892 | 17,368 | 98,709 | 106.6 K to 98.7 K (-7.40 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 2.41 | 14,244 | 34,287 | 106,601 | 120.8 K to 106.6 K (-11.79 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & Q ... | Sell | S | 2.13 | 4,963 | 10,556 | 26,310 | 31.3 K to 26.3 K (-15.87 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & Q ... | Sell | S | 2.20 | 1,714 | 3,772 | 31,273 | 33 K to 31.3 K (-5.20 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & Q ... | Sell | S | 2.41 | 3,093 | 7,445 | 32,987 | 36.1 K to 33 K (-8.57 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 2.13 | 7,117 | 15,137 | 33,174 | 40.3 K to 33.2 K (-17.66 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 2.20 | 2,457 | 5,407 | 40,291 | 42.7 K to 40.3 K (-5.75 %) |
Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 2.41 | 4,435 | 10,675 | 42,748 | 47.2 K to 42.7 K (-9.40 %) |
Dec 03 2009 | ALXA | Alexza Pharmaceuti ... | BUSSER ANDREW L | Director | Grant | A | 0.00 | 4,004 | 0 | 4,004 | 0 to 4 K |
Oct 06 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | P | 2.77 | 58,190 | 161,186 | 58,190 | |
Oct 06 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Buy | P | 2.32 | 64,655 | 150,000 | 120,845 | 56.2 K to 120.8 K (+115.06 %) |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | FRAZIER ALAN D | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
May 11 2009 | ALXA | Alexza Pharmaceuti ... | Barron Hal | Director | Option Exercise | A | 1.69 | 6,250 | 10,563 | 6,250 | |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Option Exercise | A | 2.10 | 27,277 | 57,282 | 27,277 | |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Grant | A | 0.00 | 24,419 | 0 | 28,128 | 3.7 K to 28.1 K (+658.37 %) |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | A | 2.10 | 27,277 | 57,282 | 27,277 | |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Grant | A | 0.00 | 24,419 | 0 | 33,923 | 9.5 K to 33.9 K (+256.93 %) |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 2.10 | 27,277 | 57,282 | 27,277 | |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Grant | A | 0.00 | 24,419 | 0 | 36,638 | 12.2 K to 36.6 K (+199.84 %) |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 2.10 | 54,535 | 114,524 | 54,535 | |
Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Grant | A | 0.00 | 48,822 | 0 | 56,190 | 7.4 K to 56.2 K (+662.62 %) |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Grant | A | 0.00 | 16,014 | 0 | 16,014 | 0 to 16 K |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Grant | A | 0.00 | 16,014 | 0 | 17,014 | 1,000 to 17 K (+1,601.40 %) |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Grant | A | 0.00 | 16,014 | 0 | 98,017 | 82 K to 98 K (+19.53 %) |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Barron Hal | Director | Grant | A | 0.00 | 16,014 | 0 | 16,014 | 0 to 16 K |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | FRAZIER ALAN D | Director | Grant | A | 0.00 | 17,794 | 0 | 17,794 | 0 to 17.8 K |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Grant | A | 0.00 | 18,683 | 0 | 18,683 | 0 to 18.7 K |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 2.81 | 57,877 | 162,634 | 57,877 | |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | COLELLA SAMUEL D | Director | Grant | A | 0.00 | 16,904 | 0 | 16,904 | 0 to 16.9 K |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 2.81 | 32,508 | 91,347 | 32,508 | |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | A | 2.81 | 31,220 | 87,728 | 31,220 | |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Simms Michael J | SVP, Operations & M ... | Option Exercise | A | 2.81 | 25,989 | 73,029 | 25,989 | |
Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Tebbutt Anthony G | SVP, Corp Strategy ... | Option Exercise | A | 2.81 | 30,576 | 85,919 | 30,576 | |
Aug 11 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 5.67 | 12,500 | 70,903 | 116,107 | 128.6 K to 116.1 K (-9.72 %) |
Jul 11 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 4.35 | 155,000 | 674,250 | 155,000 | |
Jul 11 2008 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 4.35 | 55,000 | 239,250 | 55,000 | |
Jul 11 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | A | 4.35 | 55,000 | 239,250 | 55,000 | |
May 28 2008 | ALXA | Alexza Pharmaceuti ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 5.33 | 6,250 | 33,313 | 6,250 | |
May 28 2008 | ALXA | Alexza Pharmaceuti ... | Read J Leighton | Director | Option Exercise | A | 5.33 | 6,250 | 33,313 | 6,250 | |
May 28 2008 | ALXA | Alexza Pharmaceuti ... | STEIN ISAAC | Director | Option Exercise | A | 5.33 | 6,250 | 33,313 | 6,250 | |
May 28 2008 | ALXA | Alexza Pharmaceuti ... | FRAZIER ALAN D | Director | Option Exercise | A | 5.33 | 6,250 | 33,313 | 6,250 | |
May 28 2008 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Option Exercise | A | 5.33 | 6,250 | 33,313 | 6,250 | |
May 16 2008 | ALXA | Alexza Pharmaceuti ... | RINGOLD GORDON | Director | Buy | P | 5.96 | 7,000 | 41,720 | 7,000 | 0 to 7 K |
May 28 2008 | ALXA | Alexza Pharmaceuti ... | COLELLA SAMUEL D | Director | Option Exercise | A | 5.33 | 6,250 | 33,313 | 6,250 | |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.25 | 100 | 625 | 128,607 | 128.7 K to 128.6 K (-0.08 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.23 | 2,500 | 15,575 | 128,707 | 131.2 K to 128.7 K (-1.91 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 5.99 | 300 | 1,797 | 131,207 | 131.5 K to 131.2 K (-0.23 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.00 | 1,600 | 9,600 | 131,507 | 133.1 K to 131.5 K (-1.20 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.01 | 600 | 3,606 | 133,107 | 133.7 K to 133.1 K (-0.45 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.05 | 2,400 | 14,520 | 133,707 | 136.1 K to 133.7 K (-1.76 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.11 | 800 | 4,888 | 136,107 | 136.9 K to 136.1 K (-0.58 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.15 | 2,700 | 16,605 | 136,907 | 139.6 K to 136.9 K (-1.93 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.16 | 1,000 | 6,160 | 139,607 | 140.6 K to 139.6 K (-0.71 %) |
May 13 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.20 | 500 | 3,100 | 140,607 | 141.1 K to 140.6 K (-0.35 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | M | 1.38 | 5,000 | 6,900 | 92,727 | |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.25 | 400 | 2,900 | 8,874 | 9.3 K to 8.9 K (-4.31 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.24 | 300 | 2,172 | 9,274 | 9.6 K to 9.3 K (-3.13 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.23 | 600 | 4,338 | 9,574 | 10.2 K to 9.6 K (-5.90 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.22 | 200 | 1,444 | 10,174 | 10.4 K to 10.2 K (-1.93 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.20 | 100 | 720 | 10,374 | 10.5 K to 10.4 K (-0.95 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.19 | 1,000 | 7,190 | 10,474 | 11.5 K to 10.5 K (-8.72 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.18 | 303 | 2,176 | 11,474 | 11.8 K to 11.5 K (-2.57 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.17 | 100 | 717 | 11,777 | 11.9 K to 11.8 K (-0.84 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.15 | 400 | 2,860 | 11,877 | 12.3 K to 11.9 K (-3.26 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.14 | 97 | 693 | 12,277 | 12.4 K to 12.3 K (-0.78 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.13 | 403 | 2,873 | 12,374 | 12.8 K to 12.4 K (-3.15 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.12 | 500 | 3,560 | 12,777 | 13.3 K to 12.8 K (-3.77 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.09 | 297 | 2,106 | 13,277 | 13.6 K to 13.3 K (-2.19 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.03 | 300 | 2,109 | 13,574 | 13.9 K to 13.6 K (-2.16 %) |
Apr 02 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Buy | M | 1.38 | 5,000 | 6,900 | 13,874 | 8.9 K to 13.9 K (+56.34 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.68 | 100 | 668 | 141,107 | 141.2 K to 141.1 K (-0.07 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.64 | 100 | 664 | 141,207 | 141.3 K to 141.2 K (-0.07 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.63 | 100 | 663 | 141,307 | 141.4 K to 141.3 K (-0.07 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.67 | 100 | 667 | 141,407 | 141.5 K to 141.4 K (-0.07 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.74 | 2,100 | 14,154 | 141,507 | 143.6 K to 141.5 K (-1.46 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.69 | 900 | 6,021 | 143,607 | 144.5 K to 143.6 K (-0.62 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.66 | 200 | 1,332 | 144,507 | 144.7 K to 144.5 K (-0.14 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.62 | 400 | 2,648 | 144,707 | 145.1 K to 144.7 K (-0.28 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.61 | 2,658 | 17,569 | 145,107 | 147.8 K to 145.1 K (-1.80 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.65 | 2,342 | 15,574 | 147,765 | 150.1 K to 147.8 K (-1.56 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.60 | 200 | 1,320 | 150,107 | 150.3 K to 150.1 K (-0.13 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.55 | 564 | 3,694 | 150,307 | 150.9 K to 150.3 K (-0.37 %) |
Feb 12 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Sell | S | 6.70 | 2,736 | 18,331 | 150,871 | 153.6 K to 150.9 K (-1.78 %) |
Jan 08 2008 | ALXA | Alexza Pharmaceuti ... | KING THOMAS BRAXTON | Pres & CEO | Option Exercise | A | 7.50 | 7,378 | 55,335 | 7,378 | |
Jan 08 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | A | 7.50 | 4,696 | 35,220 | 4,696 | |
Jan 08 2008 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 7.50 | 4,696 | 35,220 | 4,696 | |
Jan 08 2008 | ALXA | Alexza Pharmaceuti ... | Tebbutt Anthony G | SVP, Corp Strategy ... | Option Exercise | A | 7.50 | 3,830 | 28,725 | 3,830 | |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Option Exercise | M | 1.38 | 5,000 | 6,900 | 97,727 | |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 8.10 | 400 | 3,240 | 8,874 | 9.3 K to 8.9 K (-4.31 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 8.07 | 100 | 807 | 9,274 | 9.4 K to 9.3 K (-1.07 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 8.06 | 100 | 806 | 9,374 | 9.5 K to 9.4 K (-1.06 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 8.05 | 100 | 805 | 9,474 | 9.6 K to 9.5 K (-1.04 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 8.01 | 100 | 801 | 9,574 | 9.7 K to 9.6 K (-1.03 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 8.00 | 600 | 4,800 | 9,674 | 10.3 K to 9.7 K (-5.84 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.97 | 100 | 797 | 10,274 | 10.4 K to 10.3 K (-0.96 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.96 | 100 | 796 | 10,374 | 10.5 K to 10.4 K (-0.95 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.95 | 500 | 3,975 | 10,474 | 11 K to 10.5 K (-4.56 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.86 | 150 | 1,179 | 10,974 | 11.1 K to 11 K (-1.35 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.85 | 400 | 3,140 | 11,124 | 11.5 K to 11.1 K (-3.47 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.83 | 500 | 3,915 | 11,524 | 12 K to 11.5 K (-4.16 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.82 | 50 | 391 | 12,024 | 12.1 K to 12 K (-0.41 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.80 | 900 | 7,020 | 12,074 | 13 K to 12.1 K (-6.94 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.78 | 800 | 6,224 | 12,974 | 13.8 K to 13 K (-5.81 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Sell | S | 7.77 | 100 | 777 | 13,774 | 13.9 K to 13.8 K (-0.72 %) |
Jan 03 2008 | ALXA | Alexza Pharmaceuti ... | Moretti August J | SVP, CFO & Sec | Buy | M | 1.38 | 5,000 | 6,900 | 13,874 | 8.9 K to 13.9 K (+56.34 %) |